What should we expect from a bioartificial liver in fulminant hepatic failure?
Fulminant hepatic failure is associated with high mortality. Liver transplantation is an effective therapy that improves survival, and because of donor organ shortage and urgency, a bioartificial liver could act as an effective bridge to liver transplantation in patients with fulminant hepatic failure. We discuss the place of the bioartificial liver in the treatment of other causes of liver failure.
Related Questions
- What are the effects of Orfadin treatment on the incidence of liver transplantation and death due to liver failure?
- Are there histopathologic characteristics particular to fulminant hepatic failure caused by human herpesvirus-6 infection?
- Is it right to promote living donor liver transplantation for fulminant hepatic failure in pediatric recipients?
